학술논문
Impact of serum interleukin-22 as a biomarker for the differential use of molecular targeted drugs in psoriatic arthritis: a retrospective study.
Document Type
Article
Author
Source
Arthritis Research & Therapy; 4/15/2022, Vol. 24 Issue 1, p1-10, 10p
Subject
Language
ISSN
14786354